Rare Community Profiles: Dr. Brian Koffman Discusses the Complexities of Immunization for People with CLL/SLL
Fotocitizen / Pixabay

Rare Community Profiles: Dr. Brian Koffman Discusses the Complexities of Immunization for People with CLL/SLL

Rare Community Profiles     Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families,…

Continue Reading Rare Community Profiles: Dr. Brian Koffman Discusses the Complexities of Immunization for People with CLL/SLL
FDA Clears Global Phase 3 Study of Lisaftoclax for Previously Treated CLL or SLL
Source: https://pixabay.com/en/white-blood-cell-cell-blood-cell-543471/

FDA Clears Global Phase 3 Study of Lisaftoclax for Previously Treated CLL or SLL

  In Jordyn Sava's reporting from Targeted Oncology, readers learn that the U.S. Food and Drug Administration (FDA) granted clearance to a global Phase 3 study. This means that the…

Continue Reading FDA Clears Global Phase 3 Study of Lisaftoclax for Previously Treated CLL or SLL